Untargeted Plasma Metabolomic Profiling in Patients with Major Depressive Disorder Using Ultra-High Performance Liquid Chromatography Coupled with Mass Spectrometry
Major depressive disorder (MDD) is a neuropsychiatric illness with an increasing incidence and a shortfall of efficient diagnostic tools. Interview-based diagnostic tools and clinical examination often lead to misdiagnosis and inefficient systematic treatment selection. Diagnostic and treatment moni...
Main Authors: | Claudia Homorogan, Diana Nitusca, Virgil Enatescu, Philip Schubart, Corina Moraru, Carmen Socaciu, Catalin Marian |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/11/7/466 |
Similar Items
-
Plasma Metabolomics for Discovery of Early Metabolic Markers of Prostate Cancer Based on Ultra-High-Performance Liquid Chromatography-High Resolution Mass Spectrometry
by: Xiangping Lin, et al.
Published: (2021-06-01) -
Untargetted Metabolomic Exploration of the <i>Mycobacterium tuberculosis</i> Stress Response to Cinnamon Essential Oil
by: Elwira Sieniawska, et al.
Published: (2020-02-01) -
Mechanisms of bergenin treatment on chronic bronchitis analyzed by liquid chromatography-tandem mass spectrometry based on metabolomics
by: Caijuan Zhang, et al.
Published: (2019-01-01) -
Untargeted-metabolomics differentiation between poultry samples slaughtered with and without detaching spinal cord
by: Nasir Abbas, et al.
Published: (2020-12-01) -
MetaDB a Data Processing Workflow in Untargeted MS-Based Metabolomics Experiments
by: Pietro eFranceschi, et al.
Published: (2014-12-01)